DOB

4-Bromo-2,5-dimethoxyamphetamine

Brolamfetamine, Bromo-DMA, Dimethoxybromoamphetamine

Psychoactive Class

Chemical Class

Amphetamine (substituted)Amphetamine (psychedelic)Phenethylamine (substituted)

DOB is a psychedelic amphetamine of the DOx family, first synthesized by Alexander Shulgin in 1967 and later documented in depth in his 1991 book PiHKAL. It was for many years considered the most potent known phenethylamine psychedelic.¹ DOB is characterized by its unusually long duration of action and notably slow onset, which can take up to three hours — a property that increases the risk of accidental redosing.

Dosage & Duration

Dosage

Threshold~0.2 mg

Light0.2-0.75 mg

Moderate0.75-1.75 mg

Strong1.75-2.5 mg

Heavy2.5+ mg

The onset of DOB is characteristically slow, with full effects often not manifesting until one to two hours after ingestion. Attempting to redose before this onset period has concluded substantially elevates the risk of overdose. Physical stimulation and difficulty sleeping frequently outlast the main psychedelic effects and can continue for an extended period, sometimes reaching 36 hours following larger doses.

Duration

Onset30-90 minutes

Come Up120-240 minutes

Peak6-10 hours

Offset4-8 hours

After Effects4-16 hours

Total14-24 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of DOB can be broken down into five components all of which progressively intensify proportional to dosage.

Cognitive

The head space of DOB is described by many as one of mental stimulation and a powerful enhancement of a person's current mental state. Many users report that it may not be as deep as other traditional psychedelics such as LSD or Psilocin and that it is comparatively empty in terms of its insightfulness.

Acceleration of thought Time distortion Feelings of fascination, importance and awe Conceptual thinking Enhancement of current mind state Ego suppression, loss and death

Visual

Distortions

DOB presents a full and complete array of possible visual distortions.

Tracers After images Texture repetition Colour shifting Scenery slicing

Enhancements

DOB presents a full and complete array of possible visual enhancements.

Increased visual acuity Enhancement of colour Enhanced pattern recognition

Geometry

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of LSD, 25I-NBOMe or 2C-B than that of Ayahuasca, Psilocin or 2C-E. They can be comprehensively described as unstructured in their organization, algorithmic in geometric style, intricate in complexity, small in size, fast and smooth in motion, colourful in scheme, glossy in colour, sharp in their edges and equally rounded and angular in their corners. They give off a synthetic feel to them that at higher dosages are significantly more likely to result in states of Level 7A visual geometry over Level 7B.

Hallucinatory States

DOB is capable of producing a full range of low and high level hallucinatory states in a fashion that is significantly less consistent and reproducible than that of many other commonly used psychedelics.

External hallucinations

Auditory

The auditory effects of DOB are common in their occurrence and exhibit a full range of effects.

Enhancements Distortions Hallucinations

Forked from Subjective Effect Documentation

by Josie KinsApril 2014.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

DOB acts as a partial agonist at the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors, with its psychedelic effects primarily mediated through 5-HT2A activation.² It displays notable selectivity for the 5-HT2 receptor subfamily and demonstrates high efficacy in triggering downstream 5-HT2 receptor-mediated signaling.² DOB is also a very weak agonist at the human trace amine-associated receptor 1 (TAAR1). The compound is typically encountered as a racemate, with R-(−)-DOB serving as the more pharmacologically active enantiomer.²

Pharmacokinetics

DOB is extensively metabolized, with only a small amount of unchanged drug excreted. Metabolism proceeds through O-demethylation (at least partly catalyzed by CYP2D6),³⁴ oxidative deamination, and reduction to corresponding alcohols.⁴ DOB has been reported to weakly inhibit CYP2D6, though likely not to a degree sufficient to cause significant drug interactions.³ Following intravenous administration, the drug initially accumulates in the lungs before distributing to the liver and brain;⁵ after oral administration, a similar distribution pattern is observed without the initial pulmonary concentration. It has been suggested that DOB may function as a prodrug that undergoes metabolism in the lungs.⁶

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AMTLithium

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

AmphetaminesCocaineDXMPCPTramadol

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

2C-T-x compounds2C-x compounds5-MeO-xxT tryptaminesCaffeineCannabisDiphenhydramineMAOIsMDMAMephedroneMescalineMXENBOMe compoundsPregabalin

TripSit

Tolerance

Full Tolerance

Tolerance to the effects of DOB develops almost immediately after ingestion. The substance appears to have a self-regulating quality, with many users naturally spacing out their experiences.

Baseline Reset

7-10 days

Half Tolerance

4-7 days

Cross Tolerance

Serotonergic psychedelics, 5-HT2A agonists

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

DOB is not habit-forming and the desire to use it typically decreases with use. It is most often self-regulating, with many users experiencing a naturally limiting quality to the substance.

Physical

Extremely Low

DOB is not physically addictive and does not produce physical dependence or withdrawal symptoms.

Toxicity

Cardiovascular

Severe vasoconstriction is the primary toxicity concern, developing progressively and peaking several hours into intoxication; at overdose levels this has resulted in diffuse arterial spasm, peripheral vasospasm, and in extreme cases gangrene requiring amputation of extremities.⁷

Central Nervous System

Overdose can produce convulsions and seizure activity, typically occurring alongside other severe symptoms such as coma, metabolic acidosis, and cerebral edema; at typical recreational doses, the primary concerns are confusion, attention lapses, and sleep disturbances.⁸

Psychosis Risk

The long duration and stimulating nature of DOB increase the risk of psychological disturbance. Use can trigger latent psychoses, and frequent use carries risk of loss of reality that may manifest as anxiety states or schizophrenic traits. As sleep deprivation accumulates during extended experiences, stimulant psychosis may emerge with external hallucinations blending into psychedelic visuals around the 16-24 hour mark. Overdose can produce bizarre, delusional, and sometimes violent behavior.

Seizure Risk

Seizures are primarily a concern at overdose levels rather than at typical recreational doses. Convulsive activity has been documented in multiple overdose case reports, sometimes contributing to fatal outcomes.⁸ The seizure threshold may be lowered when combined with other substances such as tramadol.

History & Culture

Discovery and Early Research

DOB was first synthesized by Alexander Shulgin in 1967 as part of research examining how 4-position substitutions affect metabolic stability in phenethylamine compounds. The first published scientific report appeared in 1971, documenting toxicology findings and initial pharmacological…

Trip Reports

Legality

International

1961 Single Convention: DOB is not individually scheduled.

1971 Convention on Psychotropic Substances: DOB is scheduled in Schedule I.

1988 Convention: DOB is not listed in precursor Tables I or II.

By Country

United StatesIllegalSchedule I

21 CFR § 1308.11(d)⁶¹

Classified as a Schedule I hallucinogen under the Controlled Substances Act.⁶² Manufacturing, purchasing, possessing, or distributing without a DEA license is illegal.

AustraliaIllegalSchedule 9

Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026¹⁵¹⁶

DOB is listed as 2,5-dimethoxy-4-bromoamfetamine in Schedule 9 of the Poisons Standard. Schedule 9 identifies prohibited substances whose manufacture, possession, supply, or use should be prohibited by law except for approved medical, scientific, analytical, teaching, or training purposes.

BelgiumIllegalAnnexe IIA

Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, Annexe IIA¹⁹²⁰

Brolamfetamine (DOB) is expressly listed in Annexe IIA, which covers substances in Table I of the INCB Green List under the 1971 Convention on Psychotropic Substances. The current AFMPS consolidation has applied since 29 March 2026. The listing places DOB within the Royal Decree's psychotropic-substances control regime, subjecting its handling to the decree's authorisation controls.

CanadaIllegalSchedule I

Controlled Drugs and Substances Act, Schedule I, item 19(14)²²

DOB is expressly listed as 4-bromo-2,5-dimethoxyamphetamine in Schedule I to the Controlled Drugs and Substances Act. Except as authorized by the regulations, the Act prohibits possession, trafficking, importing, exporting and producing Schedule I substances.

ChinaIllegalNon-medical

Catalogue of Non-medical Narcotic Drugs and Psychotropic Substances²⁴

DOB is listed in China's catalogue of non-medical narcotic drugs and psychotropic substances. The non-medical catalogue prohibits unauthorised production, trade, use, storage and transport.

Czech RepublicIllegalSeznam č. 4

Government Regulation No. 463/2013 Coll. on lists of addictive substances²⁶²⁷

DOB is listed as brolamfetamine in List No. 4 of Government Regulation No. 463/2013 Coll., which sets out Czech schedules of addictive substances. Handling scheduled addictive substances, including possession, manufacture, import, export and distribution, is permitted only under the authorisation regime in Act No. 167/1998 Coll.

FinlandIllegalAnnex I

Government Decree on narcotic substances, preparations and plants (543/2008)²⁹

DOB is listed as a narcotic substance in the Finnish narcotics decree. Manufacture, import, export, sale and possession of substances in the decree require the statutory permit.

GermanyIllegalAnlage I

Betäubungsmittelgesetz, Anlage I³¹

Listed in Anlage I of the Betäubungsmittelgesetz since September 1, 1984.³¹ Manufacturing, possession, import, export, purchase, sale, and dispensing are prohibited without a license.

IndonesiaIllegalGroup I

Law No. 35 of 2009 on Narcotics³³

DOB is listed in Annex I to Indonesia's Narcotics Law as a Group I narcotic. Group I narcotics are prohibited for health-service use and are limited to authorised scientific and technological purposes.

LatviaIllegalSchedule I

Law on the Procedures for the Coming into Force and Application of the Criminal Law, Annex 2, Schedule I³⁵

Classified as a Schedule I controlled substance under Latvian drug control legislation.³⁶

NetherlandsIllegalLijst I

Opiumwet, Lijst I³⁸

Classified as a Lijst 1 substance under the Opium Act, categorizing it as a hard drug.³⁹ Production, distribution, and possession are prohibited.

NorwayIllegalNarkotikalisten

Forskrift om narkotika⁴²

DOB is included in Norway's national narcotics list as 4-bromo-2,5-dimethoxyamphetamine. The regulation treats listed substances as narcotics under the Norwegian control regime.

PolandIllegalI-P

Rozporządzenie Ministra Zdrowia w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, Annex 1⁴⁴

Listed as a controlled substance under Polish drug legislation. Possession, production, and distribution are prohibited.

RussiaIllegalList I

Government Resolution No. 681 of 30 June 1998⁴⁶

DOB is included in List I of Russia's controlled-substances list. List I covers substances whose circulation is prohibited in the Russian Federation.

South AfricaIllegalSchedule 2

Drugs and Drug Trafficking Act 140 of 1992⁴⁸

DOB is listed as an undesirable dependence-producing substance in Schedule 2 to the Drugs and Drug Trafficking Act. Use, possession and dealing are prohibited except under the medical-authorisation conditions stated in the Act.

SpainIllegalLista I

Real Decreto 2829/1977, de 6 de octubre⁵⁰

DOB is included as brolamfetamine in Lista I of Spain's psychotropic-substances schedules. Lista I substances are subject to the decree's prohibition and control regime.

SwitzerlandIllegalVerzeichnis d

Betäubungsmittelverzeichnisverordnung des EDI, Verzeichnis d⁵³

Specifically named as a controlled substance under Verzeichnis D of Swiss narcotics legislation.⁵⁴

UkraineIllegalTable I / List 2

Cabinet of Ministers Resolution No. 770 of 6 May 2000, current consolidated text⁵⁶

DOB is listed as Brolamfetamine (ДОБ, DOB) in Table I, List No. 2 of Ukraine's controlled-substances list. The list is headed ‘Especially dangerous psychotropic substances whose circulation is prohibited’; DOB is directly listed there.

United KingdomIllegalClass A / Schedule 1

Misuse of Drugs Act 1971, Schedule 2 Part I; Misuse of Drugs Regulations 2001, Schedule 1⁵⁸⁵⁹

Controlled as a Class A, Schedule 1 substance under the Misuse of Drugs Act 1971.⁶⁰ Selling, buying, or possessing without a license is illegal.

ArgentinaIllegalAnexo I

Decreto No. 772/2015, Anexo I (Listado de Sustancias Controladas); Ley No. 23.737, arts. 5, 14 and 40¹³¹⁴

DOB is named as brolanfetamine in Annex I, the List of Controlled Substances substituted by Decree No. 772/2015. Under article 40 of Law No. 23.737, substances included in lists periodically prepared and updated by presidential decree are estupefacientes; the law criminalises unauthorised production, trafficking and possession of estupefacientes.

AustriaIllegalAnhang V

Suchtgiftverordnung, Anhang V; Suchtmittelgesetz¹⁷

Prohibited under the Suchtmittelgesetz (SMG). Possession, production, and sale are illegal without authorization.¹⁸

BrazilIllegalLista F2

Portaria SVS/MS No. 344/1998²¹

DOB is listed as brolamfetamine in Lista F2 of Brazil's special-control lists. Lista F substances are prohibited under the national controlled-medicines framework.

ChileIllegalLista I

Supreme Decree No. 405 of 1983, Regulation of Psychotropic Products²³

DOB is listed in Lista I of Chile's Regulation of Psychotropic Products. The regulation prohibits manufacture, distribution, sale, possession and keeping of Lista I drugs except for authorised scientific research.

ColombiaIllegalGreen List I

Resolution No. 315 of 2020²⁵

DOB is included in Colombia's technical list of substances subject to fiscalization as a Green List I psychotropic substance. The regime controls importation, exportation, manufacture, distribution, dispensing and use of listed substances.

DenmarkIllegalListe B

Bekendtgørelse om euforiserende stoffer²⁸

DOB is included in Liste B of Denmark's order on euphoriant substances. The order regulates listed substances and preparations containing them.

FranceIllegalStupéfiants

Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants³⁰

Brolamfetamine is classified as a narcotic substance in France's national narcotics list. The classification subjects it to the French narcotics-control regime.

IndiaIllegalPsychotropic substance

Narcotic Drugs and Psychotropic Substances Act, 1985³²

DOB is listed as a psychotropic substance in the Schedule to India's Narcotic Drugs and Psychotropic Substances Act. Section 8 prohibits unauthorised production, manufacture, possession, sale, purchase, transport, use and import or export of a psychotropic substance.

JapanIllegalNarcotic

Cabinet Order Designating Narcotics, Narcotic Raw-material Plants, Psychotropic Drugs, and Narcotic and Psychotropic Raw Materials³⁴

DOB and its salts are designated narcotics under Japan's Narcotics and Psychotropics Control Act framework. Import, export, manufacture, transfer, possession and use are restricted to authorised handling.

MexicoIllegalArticle 245(I) psychotropic substance

Ley General de Salud, Articles 245(I), 248 and 249³⁷

Mexico's current consolidated General Health Law expressly lists brolamfetamine (DOB; 2,5-dimetoxi-4-bromoanfetamina) in Article 245(I). Article 248 prohibits the acts described in Article 247 in relation to substances in that group, while Article 249 permits the Health Ministry to authorise acquisition for scientific research under its controls. The Article 478 non-prosecution rule is limited to narcotics named in the Article 479 table, which does not list DOB.

New ZealandIllegalClass A

Misuse of Drugs Act 1975, Schedule 1⁴⁰⁴¹

DOB is listed in Schedule 1 to the Misuse of Drugs Act 1975 as a Class A controlled drug, identified as 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)propane, also known as bromo-DMA. The Act prohibits possessing, using, supplying, administering, manufacturing, importing, or exporting controlled drugs except as authorised.

PhilippinesIllegalDangerous drug

Republic Act No. 9165, Comprehensive Dangerous Drugs Act of 2002⁴³

DOB is a dangerous drug under the Comprehensive Dangerous Drugs Act because it is internationally scheduled under the 1971 Convention. Unauthorised importation, sale, manufacture, possession and use of dangerous drugs are criminal offences.

RomaniaControlled (high-risk)Citation needed

Classified as a controlled substance and designated as a high-risk drug under Romanian law.⁴⁵

SingaporeIllegalClass A

Misuse of Drugs Act 1973⁴⁷

DOB is a Class A controlled drug in Part I of the First Schedule to Singapore's Misuse of Drugs Act. The Act criminalises unauthorised possession, trafficking, manufacture, import, export and consumption of controlled drugs.

South KoreaIllegalPsychotropic drug

Enforcement Decree of the Narcotics Control Act⁴⁹

DOB is listed as a psychotropic drug in the Enforcement Decree of the Narcotics Control Act. Persons other than authorised narcotics handlers may not possess, use, import, export, manufacture or trade in psychotropic substances.

SwedenIllegalFörteckning I

Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika, Förteckning I; Förordning (1992:1554) om kontroll av narkotika, 3 §⁵¹⁵²

Brolamfetamin, identified as DOB and Brom-STP, is expressly listed in Sweden's Förteckning I in Läkemedelsverket's current consolidated LVFS 2011:10. The schedule is issued under 3 § of Förordning (1992:1554), which directs Läkemedelsverket to prepare and publish narcotics schedules. Schedule I covers substances that normally have no medical use.

ThailandIllegalCategory I

Notification of the Ministry of Public Health Specifying Names and Categories of Narcotics under the Narcotics Code⁵⁵

DOB is a Category I narcotic under Thailand's Narcotics Code classification. Category I narcotics may not be produced, imported, exported or possessed without the Ministry's authority.

United Arab EmiratesIllegalSchedule 6

Federal Decree-Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances⁵⁷

DOB is a Schedule 6 psychotropic substance under the UAE's Federal Decree-Law on combating narcotics and psychotropic substances. Importation, exportation, production, manufacture and possession are prohibited except in authorised cases.

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the DOB article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

DOB

4-Bromo-2,5-dimethoxyamphetamine

Brolamfetamine, Bromo-DMA, Dimethoxybromoamphetamine

Psychoactive Class

Psychedelic Stimulant Hallucinogen

Chemical Class

Amphetamine (substituted)Amphetamine (psychedelic)Phenethylamine (substituted)

Dosage & Duration

Dosage

Threshold~0.2 mg

Light0.2-0.75 mg

Moderate0.75-1.75 mg

Strong1.75-2.5 mg

Heavy2.5+ mg

Duration

Onset30-90 minutes

Come Up120-240 minutes

Peak6-10 hours

Offset4-8 hours

After Effects4-16 hours

Total14-24 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of DOB can be broken down into five components all of which progressively intensify proportional to dosage.

Cognitive

Acceleration of thought Time distortion Feelings of fascination, importance and awe Conceptual thinking Enhancement of current mind state Ego suppression, loss and death

Visual

Distortions

DOB presents a full and complete array of possible visual distortions.

Tracers After images Texture repetition Colour shifting Scenery slicing

Enhancements

DOB presents a full and complete array of possible visual enhancements.

Increased visual acuity Enhancement of colour Enhanced pattern recognition

Geometry

Hallucinatory States

External hallucinations

Auditory

The auditory effects of DOB are common in their occurrence and exhibit a full range of effects.

Enhancements Distortions Hallucinations

Forked from Subjective Effect Documentation

by Josie KinsApril 2014.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AMTLithium

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

AmphetaminesCocaineDXMPCPTramadol

Caution

Use caution

2C-T-x compounds2C-x compounds5-MeO-xxT tryptaminesCaffeineCannabisDiphenhydramineMAOIsMDMAMephedroneMescalineMXENBOMe compoundsPregabalin

TripSit

Tolerance

Full Tolerance

Tolerance to the effects of DOB develops almost immediately after ingestion. The substance appears to have a self-regulating quality, with many users naturally spacing out their experiences.

Baseline Reset

7-10 days

Half Tolerance

4-7 days

Cross Tolerance

Serotonergic psychedelics, 5-HT2A agonists

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

DOB is not habit-forming and the desire to use it typically decreases with use. It is most often self-regulating, with many users experiencing a naturally limiting quality to the substance.

Physical

Extremely Low

DOB is not physically addictive and does not produce physical dependence or withdrawal symptoms.

Toxicity

Cardiovascular

Central Nervous System

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Early Research

Trip Reports

Uncomfortable Introspection, Nihilistic Stimulationon 28/05/2014— nervewing

Trip Reports

Legality

International

1961 Single Convention: DOB is not individually scheduled.

1971 Convention on Psychotropic Substances: DOB is scheduled in Schedule I.

1988 Convention: DOB is not listed in precursor Tables I or II.

By Country

United StatesIllegalSchedule I

21 CFR § 1308.11(d)⁶¹

Classified as a Schedule I hallucinogen under the Controlled Substances Act.⁶² Manufacturing, purchasing, possessing, or distributing without a DEA license is illegal.

AustraliaIllegalSchedule 9

Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026¹⁵¹⁶

BelgiumIllegalAnnexe IIA

Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, Annexe IIA¹⁹²⁰

CanadaIllegalSchedule I

Controlled Drugs and Substances Act, Schedule I, item 19(14)²²

ChinaIllegalNon-medical

Catalogue of Non-medical Narcotic Drugs and Psychotropic Substances²⁴

DOB is listed in China's catalogue of non-medical narcotic drugs and psychotropic substances. The non-medical catalogue prohibits unauthorised production, trade, use, storage and transport.

Czech RepublicIllegalSeznam č. 4

Government Regulation No. 463/2013 Coll. on lists of addictive substances²⁶²⁷

FinlandIllegalAnnex I

Government Decree on narcotic substances, preparations and plants (543/2008)²⁹

DOB is listed as a narcotic substance in the Finnish narcotics decree. Manufacture, import, export, sale and possession of substances in the decree require the statutory permit.

GermanyIllegalAnlage I

Betäubungsmittelgesetz, Anlage I³¹

Listed in Anlage I of the Betäubungsmittelgesetz since September 1, 1984.³¹ Manufacturing, possession, import, export, purchase, sale, and dispensing are prohibited without a license.

IndonesiaIllegalGroup I

Law No. 35 of 2009 on Narcotics³³

LatviaIllegalSchedule I

Law on the Procedures for the Coming into Force and Application of the Criminal Law, Annex 2, Schedule I³⁵

Classified as a Schedule I controlled substance under Latvian drug control legislation.³⁶

NetherlandsIllegalLijst I

Opiumwet, Lijst I³⁸

Classified as a Lijst 1 substance under the Opium Act, categorizing it as a hard drug.³⁹ Production, distribution, and possession are prohibited.

NorwayIllegalNarkotikalisten

Forskrift om narkotika⁴²

DOB is included in Norway's national narcotics list as 4-bromo-2,5-dimethoxyamphetamine. The regulation treats listed substances as narcotics under the Norwegian control regime.

PolandIllegalI-P

Rozporządzenie Ministra Zdrowia w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, Annex 1⁴⁴

Listed as a controlled substance under Polish drug legislation. Possession, production, and distribution are prohibited.

RussiaIllegalList I

Government Resolution No. 681 of 30 June 1998⁴⁶

DOB is included in List I of Russia's controlled-substances list. List I covers substances whose circulation is prohibited in the Russian Federation.

South AfricaIllegalSchedule 2

Drugs and Drug Trafficking Act 140 of 1992⁴⁸

SpainIllegalLista I

Real Decreto 2829/1977, de 6 de octubre⁵⁰

DOB is included as brolamfetamine in Lista I of Spain's psychotropic-substances schedules. Lista I substances are subject to the decree's prohibition and control regime.

SwitzerlandIllegalVerzeichnis d

Betäubungsmittelverzeichnisverordnung des EDI, Verzeichnis d⁵³

Specifically named as a controlled substance under Verzeichnis D of Swiss narcotics legislation.⁵⁴

UkraineIllegalTable I / List 2

Cabinet of Ministers Resolution No. 770 of 6 May 2000, current consolidated text⁵⁶

United KingdomIllegalClass A / Schedule 1

Misuse of Drugs Act 1971, Schedule 2 Part I; Misuse of Drugs Regulations 2001, Schedule 1⁵⁸⁵⁹

Controlled as a Class A, Schedule 1 substance under the Misuse of Drugs Act 1971.⁶⁰ Selling, buying, or possessing without a license is illegal.

ArgentinaIllegalAnexo I

Decreto No. 772/2015, Anexo I (Listado de Sustancias Controladas); Ley No. 23.737, arts. 5, 14 and 40¹³¹⁴

AustriaIllegalAnhang V

Suchtgiftverordnung, Anhang V; Suchtmittelgesetz¹⁷

Prohibited under the Suchtmittelgesetz (SMG). Possession, production, and sale are illegal without authorization.¹⁸

BrazilIllegalLista F2

Portaria SVS/MS No. 344/1998²¹

DOB is listed as brolamfetamine in Lista F2 of Brazil's special-control lists. Lista F substances are prohibited under the national controlled-medicines framework.

ChileIllegalLista I

Supreme Decree No. 405 of 1983, Regulation of Psychotropic Products²³

ColombiaIllegalGreen List I

Resolution No. 315 of 2020²⁵

DenmarkIllegalListe B

Bekendtgørelse om euforiserende stoffer²⁸

DOB is included in Liste B of Denmark's order on euphoriant substances. The order regulates listed substances and preparations containing them.

FranceIllegalStupéfiants

Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants³⁰

Brolamfetamine is classified as a narcotic substance in France's national narcotics list. The classification subjects it to the French narcotics-control regime.

IndiaIllegalPsychotropic substance

Narcotic Drugs and Psychotropic Substances Act, 1985³²

JapanIllegalNarcotic

Cabinet Order Designating Narcotics, Narcotic Raw-material Plants, Psychotropic Drugs, and Narcotic and Psychotropic Raw Materials³⁴

MexicoIllegalArticle 245(I) psychotropic substance

Ley General de Salud, Articles 245(I), 248 and 249³⁷

New ZealandIllegalClass A

Misuse of Drugs Act 1975, Schedule 1⁴⁰⁴¹

PhilippinesIllegalDangerous drug

Republic Act No. 9165, Comprehensive Dangerous Drugs Act of 2002⁴³

RomaniaControlled (high-risk)Citation needed

Classified as a controlled substance and designated as a high-risk drug under Romanian law.⁴⁵

SingaporeIllegalClass A

Misuse of Drugs Act 1973⁴⁷

South KoreaIllegalPsychotropic drug

Enforcement Decree of the Narcotics Control Act⁴⁹

SwedenIllegalFörteckning I

Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika, Förteckning I; Förordning (1992:1554) om kontroll av narkotika, 3 §⁵¹⁵²

ThailandIllegalCategory I

Notification of the Ministry of Public Health Specifying Names and Categories of Narcotics under the Narcotics Code⁵⁵

DOB is a Category I narcotic under Thailand's Narcotics Code classification. Category I narcotics may not be produced, imported, exported or possessed without the Ministry's authority.

United Arab EmiratesIllegalSchedule 6

Federal Decree-Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances⁵⁷

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the DOB article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

DOB

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Visual

Distortions

Enhancements

Geometry

Hallucinatory States

Auditory

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Early Research

Trip Reports

Legality

International

By Country

References

Source Pages

Citations

Further Reading

Suggest an edit

DOB

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Visual

Distortions

Enhancements

Geometry

Hallucinatory States

Auditory

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Early Research

Trip Reports

Trip Reports

Legality

International

By Country

References

Source Pages